Novel heterocyclic compounds and uses therof
First Claim
Patent Images
1. A compound of Formula I, a tautomer, stereoisomer, or a pharmaceutically acceptable salt thereof:
3 Assignments
0 Petitions
Accused Products
Abstract
New substituted heterocyclic compounds, compositions containing them, and methods of using them for the inhibition of Raf kinase activity are provided. The new compounds and compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
-
Citations
63 Claims
- 1. A compound of Formula I, a tautomer, stereoisomer, or a pharmaceutically acceptable salt thereof:
- 41. A compound of Formula IV:
Specification